Re: Prognostic value of Ki67 expression after short-term presurgical endocrine therapy for primary breast cancer.
Hrushesky
William J M
WJ
Retsky
Michael
M
Baum
Michael
M
Demicheli
Romano
R
D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D014408:Biomarkers, Tumor; D001707:Biopsy, Needle; D001943:Breast Neoplasms / Q000737:chemistry / Q000188:drug therapy* / Q000276:immunology* / Q000601:surgery; D017024:Chemotherapy, Adjuvant; D003627:Data Interpretation, Statistical; D018572:Disease-Free Survival; D005260:Female; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D019394:Ki-67 Antigen / Q000032:analysis / Q000378:metabolism*; D008875:Middle Aged; D020360:Neoadjuvant Therapy / Q000379:methods*; D009376:Neoplasms, Hormone-Dependent / Q000737:chemistry / Q000188:drug therapy* / Q000276:immunology* / Q000601:surgery; D013997:Time Factors
D018931:Antineoplastic Agents, Hormonal; D014408:Biomarkers, Tumor; D019394:Ki-67 Antigen